Biocompatibility of <i>Bletilla striata</i> Microspheres as a Novel Embolic Agent

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/ecam/volume-2015/840896/figures/840896.fig.007a.svgz" name="840896.fig.007a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>HE (×200 times)</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/ecam/volume-2015/840896/figures/840896.fig.007b.svgz" name="840896.fig.007b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>HE (×200 times)</td></tr><tr class="fig-image" id="c"><td><object data="https://static.hindawi.com/articles/ecam/volume-2015/840896/figures/840896.fig.007c.svgz" name="840896.fig.007c" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(c) </b>HE (×200 times)</td></tr></table>

<div>((a)–(c)) Pathological results of muscle tissue at the implantation site at 1, 4, and 8 weeks.</div>

Evidence-Based Complementary and Alternative Medicine

fig7

Figure 7

Figure 7: Biocompatibility of <i>Bletilla striata</i> Microspheres as a Novel Embolic Agent 

Evidence-Based Complementary and Alternative Medicine

Biocompatibility of Bletilla striata Microspheres as a Novel Embolic Agent

Figure 7